Table 2.

Patients’ pre-therapeutic characteristics

Parameters	Series	ADT only	Cytoreduction + ADT	p
Number of cases	102	57	45	0.9
Average age (years)	71.1	70.8	71.4	0.7
Performance status
ECOG 1-2	26	12	14	0.4
ECOG 3-4	76	41	35
Clinical stage
≤T2	39	18	21	1
≥T3	63	29	34
Total PSA average (ng/mL)	1,167.7	1,438.8	824.2	0.6
Average gleason	7 (4+3)	7 (4+3)	7 (4+3)	0.6
Metastatic’ sites number
1 site	52	33	19	0.3
≥2 sites	50	27	23
Average follow-up duration	16 months	14 months	24 months	0.1